In nearly half of cancers p53 is downregulated due to overexpression of MDM2 or/and MDM4, while the other half is caused by tumorigenic missense mutations of p53, mostly occurring in DNA-binding domain (Muller and Vousden, 2013). The gene discussed is TP53; the disease is cancer.